How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Lactobacillus Acidophilus Probiotics Strains Market
- By Strain Type: Lactobacillus acidophilus La-5, Lactobacillus acidophilus NCFM, Lactobacillus acidophilus DDS-1, Lactobacillus acidophilus ATCC 4356, Lactobacillus acidophilus LA-1
- By Formulation: Capsules, Powder, Tablets, Liquid Suspensions, Chewable Tablets
- By Application: Dietary Supplements, Functional Foods and Beverages, Pharmaceuticals, Animal Feed
- By End User: Adults, Infants and Children, Elderly, Athletes
- By Distribution Channel: Online Retail, Pharmacies and Drug Stores, Health and Wellness Stores, Supermarkets and Hypermarkets
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Lactobacillus acidophilus La-5 leads By Strain Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Lactobacillus Acidophilus Probiotics Strains Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Strain Type 5
Formulation 5
Application 4
End User 4
Distribution Channel 4
Companies profiled
Chr. Hansen Holding A/S
DuPont Nutrition & Health (IFF)
Lallemand Inc.
Probi AB
Kerry Group
Morinaga Milk Industry Co. Ltd.
Yakult Honsha Co. Ltd.
Nestlé S.A.
Danone S.A.
BioGaia AB
Ganeden
Inc. (Kerry Group)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Chr. Hansen Holding A/S
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →DuPont Nutrition & Health (IFF)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Lallemand Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Probi AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Kerry Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Morinaga Milk Industry Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Yakult Honsha Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Nestlé S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Danone S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioGaia AB
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ganeden
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Inc. (Kerry Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jarrow Formulas Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Bifodan A/S
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Probiotics International Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →ADM (Archer Daniels Midland Company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$12,408M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Lactobacillus acidophilus La-554.0
- Lactobacillus acidophilus NCFM10.8
- Lactobacillus acidophilus DDS-118.7
- Lactobacillus acidophilus ATCC 43567.7
- Lactobacillus acidophilus LA-18.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,700M → $4,445M · 12.8%
Europe$1,185M → $2,615M · 10.4%
Asia Pacific$1,082M → $2,526M · 11.2%
Latin America$669.6M → $1,555M · 11.1%
Middle East and Africa$515.1M → $1,371M · 13.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.562026
11.592027
11.592028
11.612029
11.622030
11.622031
11.642032
11.652033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Chr. Hansen Holding A/S22.4
- DuPont Nutrition & Health (IFF)17.9
- Lallemand Inc.4.8
- Probi AB13.6
- Kerry Group8.0
- Morinaga Milk Industry Co. Ltd.5.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Strain Type15.9%
Formulation20.9%
Application22.8%
End User24.7%
Distribution Channel15.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.5
- Europe20.9
- Asia Pacific20.2
- Latin America12.4
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Chr. Hansen Holding A/S | 85 | 93 | 83 | 90 | 81 | 92 | 87 |
| DuPont Nutrition & Health (IFF) | 68 | 80 | 87 | 70 | 79 | 74 | 76 |
| Lallemand Inc. | 66 | 64 | 72 | 85 | 63 | 71 | 70 |
| Probi AB | 61 | 72 | 67 | 79 | 60 | 61 | 67 |
| Kerry Group | 76 | 53 | 62 | 61 | 72 | 59 | 64 |
| Morinaga Milk Industry Co. Ltd. | 63 | 70 | 47 | 47 | 53 | 61 | 57 |
| Yakult Honsha Co. Ltd. | 52 | 61 | 56 | 41 | 57 | 45 | 52 |
| Nestlé S.A. | 51 | 49 | 53 | 57 | 43 | 47 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Chr. Hansen Holding A/S
- DuPont Nutrition & Health (IFF)
- Lallemand Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Chr. Hansen Holding A/S | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| DuPont Nutrition & Health (IFF) | − | ◐ | ◐ | ◐ | ◐ | ✓ |
| Lallemand Inc. | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Probi AB | − | ◐ | ✓ | ◐ | ◐ | − |
| Kerry Group | ◐ | − | − | ◐ | − | − |
| Morinaga Milk Industry Co. Ltd. | ◐ | ◐ | − | − | − | ◐ |
| Yakult Honsha Co. Ltd. | − | ◐ | ◐ | − | − | − |
| Nestlé S.A. | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Chr. Hansen Holding A/S87
2DuPont Nutrition & Health (IFF)76
3Lallemand Inc.70
4Probi AB67
5Kerry Group64
6Morinaga Milk Industry Co. Ltd.57
7Yakult Honsha Co. Ltd.52
8Nestlé S.A.50
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Chr. Hansen Holding A/S
Challenger3
Strong scale, closing on the leaders.
DuPont Nutrition & Health (IFF)Lallemand Inc.Probi AB
Contender2
Focused players with pockets of strength.
Kerry GroupMorinaga Milk Industry Co. Ltd.
Niche2
Specialists in a single segment or region.
Yakult Honsha Co. Ltd.Nestlé S.A.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Strain Type in North America, then scale across Lactobacillus Acidophilus Probiotics Strains Market — a $147M beachhead inside a $2.54B market.
Beachhead (SOM)$147Mobtainable near-term
Serviceable (SAM)$997Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Lactobacillus acidophilus La-5
Best fit — highest urgency & budget in Strain Type.
Economic buyer80 fit
Lactobacillus acidophilus NCFM
Strong fit — clear ROI and a fast path to value.
End user65 fit
Lactobacillus acidophilus DDS-1
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Strain Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel25%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Strain Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Lactobacillus Acidophilus Probiotics Strains Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation12%
Closed-won5%
$10.7KCAC
$62KLTV
5.8:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Lactobacillus Acidophilus Probiotics Strains Market is a high-growth opportunity — $6.21B by 2033, compounding at 11.1%.
TAM · 2025$2.68Btoday
TAM · 2033$6.21Bforecast
CAGR11.1%2027–2033
Cumulative$38.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.21BTotal addressable market
SAM$2.58BServiceable available market
SOM$479MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.1% CAGR
Demand compounds through 2033, outpacing GDP across Strain Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Strain Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.21BLarge & growingTAM by 2033 at 11.1% CAGR
$2.58BServiceable nowreachable with today’s model
$479MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.84BBear7.2% CAGR
$6.21BBase11.1% CAGR
$7.94BBull14.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Lactobacillus Acidophilus Probiotics Strains Market — a $5.16B market by 2033. Plan: grow share from 8.2% to 13.1%.
Market size · 2033$5.16Btotal addressable
Market CAGR5.0%2027–2033
Target share13.1%from 8.2% today
Revenue ambition$676Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 13.1% | On track |
| Revenue | $429M | $676M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 31.1% | 42.6% | Ahead |
| Customer retention | 91.8% | 92.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Strain Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation capability
A defensible second engine — invest in Formulation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Strain Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $100M capacity & capability investment
- Greenlight bolt-on M&A in Formulation
- Authorise North America expansion plan
- Fund R&D program for Strain Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Lactobacillus Acidophilus Probiotics Strains Market conversation — a $2.78B market you can size, segment and defend in minutes.
Market size · 2033$2.78Btotal opportunity
Growth3.7%CAGR to 2033
Addressable buyers1,559+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Strain Type
Goal Grow share in Strain Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 4 mopayback period
$76K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Chr. Hansen Holding A/SDuPont Nutrition & Health (IFF)Lallemand Inc.Probi ABKerry GroupMorinaga Milk Industry Co. Ltd.Yakult Honsha Co. Ltd.Nestlé S.A.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Lactobacillus Acidophilus Probiotics Strains Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Lactobacillus Acidophilus Probiotics Strains Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Lactobacillus Acidophilus Probiotics Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportLactic Acid Bacteria Tablet Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportLactic Acid Analyzers Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportLACTB2 Antibody Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportLactation Support Supplements Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportLactation Supplements Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportLactation Massager Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportLactate Test Meters Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportLactated Ringer’s Injection Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportLactate dehydrogenase Test Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportLactate Dehydrogenase Reagents Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportLactate Assay Kits Market
Market size, share, segmentation and regional forecast.
$926M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.